[1] |
Bryarly M, Phillips LT, Fu Q, et al. Postural orthostatic tachycardia syndrome: JACC focus seminar[J]. J Am Coll Cardiol, 2019, 73(10): 1207-1028.
|
[2] |
Stewart JM, Gewitz MH, Weldon A, et al. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue[J]. J Pediatr, 1999, 135(2 Pt 1): 218-225.
doi: 10.1016/S0022-3476(99)70025-9
|
[3] |
Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome[J]. CMAJ, 2022, 194(10): E378-E385.
|
[4] |
张清友, 杜军保, 李万镇. 儿童体位性心动过速综合征的临床特征及随访研究[J]. 中华儿科杂志, 2005, 43(3): 165-169.
|
[5] |
Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management[J]. J Intern Med, 2019, 285(4): 352-366.
doi: 10.1111/joim.12852
pmid: 30372565
|
[6] |
Wang Y, Du J, Jin H, et al. Comorbidity of neurally mediated syncope and allergic disease in children[J]. Front Immunol, 2020, 11: 1865.
doi: 10.3389/fimmu.2020.01865
|
[7] |
Wang Y, Du J, Li X, et al. Impact of comorbidities on the prognosis of pediatric postural tachycardia syndrome[J]. Int J Gen Med, 2021, 14: 8945-8954.
doi: 10.2147/IJGM.S339805
|
[8] |
Zhao J, Han Z, Zhang X, et al. A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension[J]. BMJ Open, 2015, 5(6): e007356.
doi: 10.1136/bmjopen-2014-007356
|
[9] |
Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope[J]. Heart Rhythm, 2015, 12(6): e41-e63.
|
[10] |
Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. Circulation, 2017, 136(5): e60-e122.
|
[11] |
Wang C, Li Y, Liao Y, et al. 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents[J]. Sci Bull, 2018, 63: 1558-1564.
doi: 10.1016/j.scib.2018.09.019
|
[12] |
Moon J, Lee HS, Byun JI, et al. The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability[J]. J Am Soc Hypertens, 2016, 10(3): 263-270.
doi: 10.1016/j.jash.2016.01.011
|
[13] |
Liao Y, Du J. Pathophysiology and individualized management of vasovagal syncope and postural tachycardia syndrome in children and adolescents: an update[J]. Neurosci Bull, 2020, 36(6): 667-681.
doi: 10.1007/s12264-020-00497-4
|
[14] |
Kharraziha I, Axelsson J, Ricci F, et al. Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome[J]. J Am Heart Assoc, 2020, 9(15): e015989.
doi: 10.1161/JAHA.120.015989
|
[15] |
Gunning WT 3rd, Kvale H, Kramer PM, et al. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies[J]. J Am Heart Assoc, 2019, 8(18): e013602.
doi: 10.1161/JAHA.119.013602
|
[16] |
Monaco A, Choi D, Uzun S, et al. Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature[J]. Immunol Res, 2022: 1-13.
|
[17] |
Chen G, Du J, Jin H, et al. Postural tachycardia syndrome in children and adolescents: pathophysiology and clinical management[J]. Front Pediatr, 2020, 8: 474.
doi: 10.3389/fped.2020.00474
|
[18] |
Blitshteyn S. Vitamin B 1 deficiency in patients with postural tachycardia syndrome (POTS)[J]. Neurol Res, 2017, 39(8): 685-688
doi: 10.1080/01616412.2017.1331895
pmid: 28531358
|
[19] |
Do T, Diamond S, Green C, et al. Nutritional implications of patients with dysautonomia and hypermobility syndromes[J]. Curr Nutr Rep, 2021, 10(4): 324-333.
doi: 10.1007/s13668-021-00373-1
|
[20] |
Lin J, Zhao H, Shen J, et al. Salivary cortisol levels predict therapeutic response to a sleep-promoting method in children with postural tachycardia syndrome[J]. J Pediatr, 2017, 191: 91-95.
doi: 10.1016/j.jpeds.2017.08.039
|
[21] |
George SA, Bivens TB, Howden EJ, et al. The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting[J]. Heart Rhythm, 2016, 13(4): 943-950.
doi: 10.1016/j.hrthm.2015.12.012
|
[22] |
Garland EM, Gamboa A, Nwazue VC, et al. Effect of high dietary sodium intake in patients with postural tachycardia syndrome[J]. J Am Coll Cardiol, 2021, 77(17): 2174-2184.
doi: 10.1016/j.jacc.2021.03.005
pmid: 33926653
|
[23] |
廖莹, 杜军保. 儿童血管迷走性晕厥及体位性心动过速综合征治疗专家共识解读[J]. 中华儿科杂志, 2018, 56 (1): 10-12.
|
[24] |
Zhang Q, Xu B, Du J. Update of Individualized treatment strategies for postural orthostatic tachycardia syndrome in children[J]. Front Neurol, 2020, 11: 525.
doi: 10.3389/fneur.2020.00525
|
[25] |
Li H, Wang Y, Liu P, et al. Body mass index (BMI) is associated with the therapeutic response to oral rehydration solution in children with postural tachycardia syndrome[J]. Pediatr Cardiol, 2016, 37(7): 1313-1318
doi: 10.1007/s00246-016-1436-1
|
[26] |
Lu W, Yan H, Wu S, et al. Hemocytometric measures predict the efficacy of oral rehydration for children with postural tachycardia syndrome[J]. J Pediatr, 2017, 187: 220-224.
doi: 10.1016/j.jpeds.2017.04.034
|
[27] |
Li H, Liao Y, Wang Y, et al. Baroreflex sensitivity predicts short-term outcome of postural tachycardia syndrome in children[J]. PLoS One, 2016, 11(12): e0167525.
doi: 10.1371/journal.pone.0167525
|
[28] |
Miller AJ, Raj SR. Pharmacotherapy for postural tachycardia syndrome[J]. Auton Neurosci, 2018, 215: 28-36.
doi: 10.1016/j.autneu.2018.04.008
|
[29] |
Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1 [J]. Auton Neurosci, 2021, 235: 102828.
doi: 10.1016/j.autneu.2021.102828
|
[30] |
Lin J, Han Z, Li H, et al. Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome[J]. PLoS One, 2015, 10(3): e0121913.
doi: 10.1371/journal.pone.0121913
|
[31] |
Wang YY, Han ZH, Wang YL, et al. Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy[J]. Chin Med J (Engl), 2021, 134(16): 1977-1982.
|
[32] |
Wang Y, Zhang C, Chen S, et al. Heart rate variability predicts therapeutic response to metoprolol in children with postural tachycardia syndrome[J]. Front Neurosci, 2019, 13: 1214.
doi: 10.3389/fnins.2019.01214
|
[33] |
Mar PL, Raj SR. Postural orthostatic tachycardia syndrome: mechanisms and new therapies[J]. Annu Rev Med, 2020, 71: 235-248.
doi: 10.1146/annurev-med-041818-011630
|
[34] |
Wang S, Zou R, Cai H, et al. Predictive value of heart rate and blood pressure on the prognosis of postural tachycardia syndrome in children[J]. Front Pediatr, 2022, 10: 802469.
doi: 10.3389/fped.2022.802469
|
[35] |
Yan H, Wang S, Cai H, et al. Prognostic value of biomarkers in children and adolescents with orthostatic intolerance[J]. Front Pediatr, 2021, 9: 752123.
doi: 10.3389/fped.2021.752123
|
[36] |
Bai W, Chen SY, Jin HF, et al. Vascular dysfunction of postural tachycardia syndrome in children[J]. World J Pediatr, 2018, F14(1):13-17.
|
[37] |
Bruce BK, Harrison TE, Bee SM, et al. Improvement in functioning and psychological distress in adolescents with postural orthostatic tachycardia syndrome following interdisciplinary treatment[J]. Clin Pediatr (Phila), 2016, 55(14): 1300-1304.
doi: 10.1177/0009922816638663
|
[38] |
de Asmundis C, Chierchia GB, Sieira J, et al. Sinus node sparing novel hybrid approach for treatment of inappropriate sinus tachycardia/postural orthostatic sinus tachycardia with new electrophysiological finding[J]. Am J Cardiol 2019, 124(2): 224-232.
doi: S0002-9149(19)30458-8
pmid: 31084999
|